Apogee Therapeutics, Inc. (APGE)
Sept 3, 2026 - APGE was delisted (reason: acquired by ABBV)
135.07
0.00 (0.00%)
Inactive · Last trade price on Sep 3, 2026
Apogee Therapeutics Employees
Apogee Therapeutics had 261 employees as of December 31, 2025. The number of employees increased by 65 or 33.16% compared to the previous year.
Employees
261
Change (1Y)
65
Growth (1Y)
33.16%
Revenue / Employee
n/a
Profits / Employee
-$1,127,866
Market Cap
10.19B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 261 | 65 | 33.16% |
| Dec 31, 2024 | 196 | 105 | 115.38% |
| Dec 31, 2023 | 91 | - | - |
APGE News
- 8 days ago - AbbVie Completes Acquisition of Apogee Therapeutics - PRNewsWire
- 4 weeks ago - Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates - GlobeNewsWire
- 4 weeks ago - Apogee Therapeutics Earnings release: Q2 2026 - Filings
- 4 weeks ago - Apogee Therapeutics Quarterly report: Q2 2026 - Filings
- 5 weeks ago - Apogee Therapeutics Proxy statement: Proxy filing - Filings
- 5 weeks ago - Apogee Therapeutics Proxy statement: Proxy filing - Filings
- 1 month ago - Big Pharma's $300 Billion Patent Problem Fuels Biotech Deals - ETF Trends
- 2 months ago - Apogee Therapeutics Proxy statement: Proxy filing - Filings